These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Listed as ongoing, but also has a completion date||2010-021258-20||Early treatment of Atrial fibrillation for Stroke prevention Trial (EAST)||2020-05-29||bad-data|
|Not reported||2014-002442-45||Anticoagulation using the direct factor Xa inhibitor apixaban during Atrial Fibrillation catheter Ablation: Comparison to vitamin K antagonist therapy.||2017-09-12||due-trials|
|Ongoing||2015-003997-33||Non-vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes||not-yet-due|
|Ongoing||2015-005503-84||A Safety Study Assessing Oral Anticoagulation with Apixaban versus Vitamin-K Antagonists in Patients with Atrial Fibrillation and End-Stage Kidney Disease (ESKD) on Chronic Hemodialysis Treatment.||not-yet-due|